BALDISH KHERA: Open Payments
NPI 1336777424 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 14 payments from 7 companies in 2025. Trend: 2023 $168 · 2024 $148 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $159 |
| Novo Nordisk Inc | 4 | $89 |
| Corcept Therapeutics | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: REPATHA, Ozempic, OTEZLA, Korlym, APTIMA, SHINGRIX, Veozah, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
